STOCK TITAN
  1. Home
  2. SEC Filings
  3. AYI
  4. [Form 4] ACUITY INC. (DE) Insider Trading Activity

Acuity CEO Neil Ashe sells 30,247 shares under plan

The per-share amounts are weighted averages; underlying executions were reported within price bands spanning $314.32 to $327.76.

Available on EDGAR Accepted by SEC EDGAR
Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
4

Rhea-AI Filing Summary

Acuity Inc. President & CEO Neil Ashe reported 15 direct sales totaling 30,247 shares of common stock on October 28 and October 29, 2026. The sales occurred automatically under a Rule 10b5-1 trading plan adopted July 1, 2026. Reported weighted-average prices ranged from $314.53 to $327.30 per share; footnotes state that underlying sales were executed at prices ranging from $314.32 to $327.76.

Insider ASHE NEIL
Role President & CEO
Sold 30,247 shs ($9.66M)
Type Security Shares Price Value
Sale Common Stock F1, F8 240 $316.28 $76K
Sale Common Stock F1, F9 120 $318.09 $38K
Sale Common Stock F1, F10 400 $320.69 $128K
Sale Common Stock F1, F11 720 $321.84 $232K
Sale Common Stock F1, F12 240 $323.01 $78K
Sale Common Stock F1, F13 1,320 $324.37 $428K
Sale Common Stock F1, F14 3,512 $325.30 $1.14M
Sale Common Stock F1, F15 1,155 $326.29 $377K
Sale Common Stock F1, F16 480 $327.30 $157K
Sale Common Stock F1, F2 707 $314.53 $222K
Sale Common Stock F1, F3 5,286 $316.14 $1.67M
Sale Common Stock F1, F4 6,544 $317.03 $2.07M
Sale Common Stock F1, F5 7,295 $318.22 $2.32M
Sale Common Stock F1, F6 1,948 $318.84 $621K
Sale Common Stock F1, F7 280 $320.00 $90K
Holdings After Transaction: Common Stock — 78,075 shares (Direct)
Footnotes (16)
  1. F1. The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.32 to $315.31, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.55 to $316.54, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.55 to $317.52, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.59 to $318.59, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  6. F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.61 to $319.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  7. F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.28 to $318.09, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  8. F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.14 to $316.98, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  9. F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.51 to $318.41, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  10. F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.11 to $321.02, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  11. F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.45 to $322.32 inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  12. F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.59 to $323.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  13. F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.91 to $324.69, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  14. F14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.92 to $325.86, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  15. F15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.92 to $326.87, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  16. F16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $326.94 to $327.76, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Shares sold 30,247 shares Across 15 direct sales on October 28 and October 29, 2026
Reported sales 15 transactions Direct common stock sales on October 28 and October 29, 2026
Weighted-average sale price $314.53 per share For 707 shares sold October 28, 2026
Weighted-average sale price $327.30 per share For 480 shares sold October 29, 2026
Trading plan adoption date July 1, 2026 Rule 10b5-1 trading plan
Rule 10b5-1 trading plan regulatory
"automatically pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Reporting Person regulatory
"adopted by the Reporting Person on July 1, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AYI shares did Neil Ashe sell?
Neil Ashe reported selling 30,247 shares across 15 direct sales on October 28 and October 29, 2026. The sales occurred automatically under a Rule 10b5-1 trading plan adopted July 1, 2026.

What prices were reported for Neil Ashe’s AYI sales?
Reported weighted-average sale prices ranged from $314.53 to $327.30 per share. Footnotes state that the underlying sale executions occurred at prices ranging from $314.32 to $327.76.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ASHE NEIL
(Last)(First)(Middle)
C/O ACUITY INC.
1170 PEACHTREE STREET, NE, SUITE 1200
(Street)
ATLANTA GEORGIA 30309
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ACUITY INC. (DE) [ AYI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/28/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/28/2026S(1)707D$314.53(2)107,615D
Common Stock10/28/2026S(1)5,286D$316.14(3)102,329D
Common Stock10/28/2026S(1)6,544D$317.03(4)95,785D
Common Stock10/28/2026S(1)7,295D$318.22(5)88,490D
Common Stock10/28/2026S(1)1,948D$318.84(6)86,542D
Common Stock10/28/2026S(1)280D$320(7)86,262D
Common Stock10/29/2026S(1)240D$316.28(8)86,022D
Common Stock10/29/2026S(1)120D$318.09(9)85,902D
Common Stock10/29/2026S(1)400D$320.69(10)85,502D
Common Stock10/29/2026S(1)720D$321.84(11)84,782D
Common Stock10/29/2026S(1)240D$323.01(12)84,542D
Common Stock10/29/2026S(1)1,320D$324.37(13)83,222D
Common Stock10/29/2026S(1)3,512D$325.3(14)79,710D
Common Stock10/29/2026S(1)1,155D$326.29(15)78,555D
Common Stock10/29/2026S(1)480D$327.3(16)78,075D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The transaction reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2026.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.32 to $315.31, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.55 to $316.54, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.55 to $317.52, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.59 to $318.59, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.61 to $319.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.28 to $318.09, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.14 to $316.98, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.51 to $318.41, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.11 to $321.02, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.45 to $322.32 inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.59 to $323.46, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.91 to $324.69, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.92 to $325.86, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.92 to $326.87, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $326.94 to $327.76, inclusive. The Reporting Person undertakes to provide to Acuity Inc., any security holder of Acuity Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Remarks:
/s/ Chanda Kirchner, Attorney-in-Fact for Neil Ashe10/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on AYI

All AYI news

Trending in the feed

MRNA
Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates Open the live feed